Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

6.34

+0.13 (2.09%)

At close: Aug 7, 2026, 4:00 PM EDT

6.34

0.00 (-0.01%)

After-hours: Aug 7, 2026, 7:57 PM EDT

Iovance Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-289.52	-390.98	-372.18	-444.04	-395.89	-342.25
Depreciation & Amortization	45.14	47.32	48.07	33.13	21.14	13.98
Stock-Based Compensation	46.72	61.58	109.63	62.63	84.02	69.77
Other Adjustments	-1.62	3.94	-11.48	-7.01	0.87	6.01
Change in Receivables	-42.18	-13.11	-69.19	-0.15	-	-
Changes in Inventories	-12.13	-14.21	-44.38	-	-	-
Changes in Accounts Payable	-5.54	-6.66	-7.84	4.83	5.88	6.98
Changes in Accrued Expenses	-2.99	28.64	8.58	19.77	-4.7	20.68
Changes in Other Operating Activities	-0.77	-18.14	-14.19	-20.86	-4.07	-3.11
Operating Cash Flow	-264.18	-302.41	-352.98	-361.82	-292.76	-227.94
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-32.21	-33.84	-11.07	-22.29	-20.43	-37.57
Purchases of Investments	-337.66	-318.67	-460.77	-205.9	-245.82	-725.21
Proceeds from Sale of Investments	325	400	428	285.58	522.7	762.91
Cash Acquisitions	-	-	-52.57	-212.63	-	-
Investing Cash Flow	-44.87	47.5	-96.41	-155.24	256.46	0.13
Long-Term Debt Issued	-	-	-	-	-	1
Net Long-Term Debt Issued (Repaid)	-	-	-	-	-	1
Issuance of Common Stock	238.33	307.83	403.52	465.75	192.8	238.27
Repurchase of Common Stock	-6.26	-7.06	-12.86	-2.8	-2.65	-
Net Common Stock Issued (Repurchased)	232.07	300.77	390.66	462.96	190.15	238.27
Financing Cash Flow	287.85	300.77	390.66	462.96	190.15	239.27
Foreign Exchange Rate Adjustments	-0.44	1.14	-0.54	-2.74	-	-
Net Cash Flow	-21.64	47.01	-59.27	-56.84	153.85	11.46
Free Cash Flow	-296.4	-336.24	-364.05	-384.11	-313.18	-265.52
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-59.79%	-127.61%	-221.89%	-32305.30%	-	-
Free Cash Flow Per Share	-0.72	-0.94	-1.26	-1.63	-1.97	-1.73
Levered Free Cash Flow	-298.01	-387.87	-393.01	-429.45	-398.08	-340.29
Unlevered Free Cash Flow	-305.44	-398.12	-413.13	-442.4	-401.06	-341.74

SEC Filings: 10-K · 10-Q